A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, David Liu et al.|Cell|2018Cited by 1.5k
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Eytan Ruppin, Gao Zhang et al.|Nature Medicine|2018Cited by 813
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R. Parikh, Ryan B. Corcoran, Emily E. Van Seventer et al.|Clinical Cancer Research|2021Cited by 358
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Genevieve M. Boland, Jia‐Ren Lin et al.|Nature Medicine|2021Cited by 135
916 Acquired resistance to immune checkpoint blockade by phenotypic plasticity of melanomaEmily Robitschek, Ryan J. Sullivan, Arnav Mehta et al.|Regular and Young Investigator Award Abstracts|2022Cited by 1